UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

Neurology, 1998-05, Vol.50 (5), p.1323-1326

1998

Volltextzugriff (PDF)

Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine

Neurology, 2002-09, Vol.59 (5), p.694-699

2002

Volltextzugriff (PDF)

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease

Experimental neurology, 2003-11, Vol.184 (1), p.285-294

2003

Volltextzugriff (PDF)

Translating A2A antagonist KW6002 from animal models to parkinsonian patients

Neurology, 2003-12, Vol.61 (11 Suppl 6), p.S107

2003

Volltextzugriff (PDF)

The Functional Neuroanatomy of Tourette's Syndrome: An FDG PET Study III: Functional Coupling of Regional Cerebral Metabolic Rates

Neuropsychopharmacology (New York, N.Y.), 2002-07, Vol.27 (1), p.92-104

2002

Volltextzugriff (PDF)

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

Trends in neurosciences (Regular ed.), 2000-10, Vol.23 (10), p.S86-S91

2000

Volltextzugriff (PDF)

Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys

Annals of neurology, 1996-05, Vol.39 (5), p.574-578

1996

Volltextzugriff (PDF)

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease

Drugs (Basel), 1998, Vol.55, p.1-9

CHASE, T. N

1998

Volltextzugriff (PDF)

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

Neurology, 1998-07, Vol.51 (1), p.203-206

1998

Volltextzugriff (PDF)

Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys

Movement disorders, 1998-09, Vol.13 (5), p.798-802

1998

Volltextzugriff (PDF)

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration

Brain research, 1998-11, Vol.813 (1), p.150-159

1998

Volltextzugriff (PDF)

Neostriatal mechanisms in Parkinson's disease

Neurology, 1998-08, Vol.51 (2 Suppl 2), p.S30

1998

Volltextzugriff (PDF)

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Movement disorders, 2001-05, Vol.16 (3), p.515-520

2001

Volltextzugriff (PDF)

Wearing-off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms

Annals of neurology, 1994-07, Vol.36 (1), p.27-31

1994

Volltextzugriff (PDF)

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

Science (American Association for the Advancement of Science), 1990-12, Vol.250 (4986), p.1429-1432

1990

Volltextzugriff (PDF)

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits

Brain research, 1999-03, Vol.821 (2), p.433-442

1999

Volltextzugriff (PDF)

Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications

Neurology, 1997-02, Vol.48 (2), p.369-372

1997

Volltextzugriff (PDF)

Changed distribution pattern of the constitutive rather than the inducible HSP70 chaperone in neuromelanin-containing neurones of the Parkinsonian midbrain

Neuropathology and applied neurobiology, 2006-04, Vol.32 (2), p.157-169

2006

Volltextzugriff (PDF)

MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats

Brain research, 1996-10, Vol.736 (1), p.202-205

1996

Volltextzugriff (PDF)

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

Brain research, 1994-10, Vol.662 (1), p.69-74

1994

Volltextzugriff (PDF)

Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients

Neurology, 1993-12, Vol.43 (12), p.2685-2685

1993

Volltextzugriff (PDF)

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

Neurology, 2001-11, Vol.57 (10), p.1829-1834

2001

Volltextzugriff (PDF)

A trial of dextromethorphan in parkinsonian patients with motor response complications

Movement disorders, 1998-05, Vol.13 (3), p.414-417

1998

Volltextzugriff (PDF)

Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging

Neurology, 1996-09, Vol.47 (3), p.696-704

1996

Volltextzugriff (PDF)

NMDA receptor blockade reverses motor response alterations induced by levodopa

Neuroreport, 1994-12, Vol.5 (18), p.2586-2588

1994

Volltextzugriff (PDF)

1 – 25 von 343

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(326)
Mit Volltextzugriff
(259)

Publikationsform

Artikel
(341)
Tagungsberichte
(2)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(343)
Science & Technology
(267)
Life Sciences & Biomedicine
(265)
Humans
(235)
Male
(201)
Female
(155)
Neurosciences & Neurology
(148)
Middle Aged
(132)
Pharmacology. Drug Treatments
(129)
Clinical Neurology
(111)
Neuropharmacology
(97)
Aged
(91)
Adult
(90)
Neurology
(87)
Animals
(74)
Neurosciences
(64)
Anticonvulsants. Antiepileptics. Antiparkinson Agents
(54)
Parkinson Disease - Drug Therapy
(49)
Rats
(49)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neurology
(33)
Annals Of Neurology
(20)
Movement Disorders
(18)
Archives Of Neurology
(12)
Brain Research
(12)
Optometry And Vision Science
(12)
Clinical Neuropharmacology
(11)
European Journal Of Pharmacology
(11)
Journal Of Neurology, Neurosurgery And Psychiatry
(10)
Blood
(9)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease

Translating A2A antagonist KW6002 from animal models to parkinsonian patients

The Functional Neuroanatomy of Tourette's Syndrome: An FDG PET Study III: Functional Coupling of Regional Cerebral Metabolic Rates

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration

Neostriatal mechanisms in Parkinson's disease

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Wearing-off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits

Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications

Changed distribution pattern of the constitutive rather than the inducible HSP70 chaperone in neuromelanin-containing neurones of the Parkinsonian midbrain

MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

A trial of dextromethorphan in parkinsonian patients with motor response complications

Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging

NMDA receptor blockade reverses motor response alterations induced by levodopa

Aktive Filter

Suchergebnisse filtern